Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: GenSight raises EUR 40M in Euronext IPO

    Gene therapy company GenSight Biologics S.A. (Euronext:SIGHT) raised EUR 40 million ($44.1 million) through the sale of 5 million shares at EUR 8 in an IPO on Euronext Paris. The offering valued the company at about EUR…

    Published on 7/13/2016
  • FINANCIAL NEWS: GW raises $252M in follow-on

    GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH) raised $252 million through the sale of 2.8 million ADSs at $90 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Goldman Sachs, Cowen and Piper Jaffray. GW…

    Published on 7/13/2016
  • FINANCIAL NEWS: Pharnext listing brings in EUR 30.9M

    Pharnext S.A.S. (Euronext:ALPHA) raised EUR 30.9 million ($34.1 million) through the sale of 2.9 million shares at EUR 10.82 in an IPO on Euronext Paris. Gilbert Dupont is the underwriter. The offering valued Pharnext …

    Published on 7/13/2016
  • FINANCIAL NEWS: Polaris targeting $400M for next fund

    Polaris Partners is targeting $400 million for Polaris Partners VIII, according to an SEC filing. The firm declined to discuss the new fund. In 2014, Polaris closed its seventh fund at $450 million. It invested the fund…

    Published on 7/13/2016
  • FINANCIAL NEWS: Cancer newco Sapience raises $22.5M

    Sapience Therapeutics Inc. (Scarsdale, N.Y.) raised $22.5 million in an untranched series A round led by Eshelman Ventures. Celgene Corp. (NASDAQ:CELG), TaiAn Technologies and Healthlink Capital also participated. …

    Published on 7/12/2016
  • FINANCIAL NEWS: Longwood raising new fund

    Longwood Fund has set a $90 million target for Longwood Fund IV, according to an SEC filing. The firm did not respond to inquiries.Longwood's portfolio includes endocrine disease play Millendo Therapeutics Inc. (Ann …

    Published on 7/12/2016
  • FINANCIAL NEWS: Protagonist files for IPO

    Protagonist Therapeutics Inc. (Milpitas, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Leerink, Barclays and BMO Capital Markets. Protagonist develops oral peptides to treat …

    Published on 7/12/2016
  • FINANCIAL NEWS: Computational pathology play 3Scan raises $14M

    3Scan (San Francisco, Calif.) raised $14 million in a series B round led by existing investors Lux Capital and Data Collective. Also participating were the investment arm of an undisclosed U.S. research hospital, …

    Published on 7/11/2016
  • FINANCIAL NEWS: GenSight now eying Euronext

    Gene therapy company GenSight Biologics S.A. (Paris, France) is proposing to raise about EUR 40 million ($44.3 million) in a listing on Euronext Paris. The company is targeting a price range of EUR 7.80-EUR 9.20 and …

    Published on 7/8/2016
  • FINANCIAL NEWS: Lux's Bock passes away

    Serial life sciences investor Larry Bock passed away from pancreatic cancer.Bock, who was 56, was a special LP at Lux Capital, and prior to that was co-founder and executive chairman of Nanosys Inc. (Palo Alto, Calif.),…

    Published on 7/8/2016
  • FINANCIAL NEWS: Aslan raises $23M in pre-IPO round

    Cancer biotech Aslan Pharmaceuticals Pte. Ltd. (Singapore) raised $23 million in a series D round from new and existing investors. New investors included TopTaiwan, KGI VC, Ta Ya Ventures, Milestone Capital, Daiwa …

    Published on 7/5/2016
  • FINANCIAL NEWS: BioGeneration raises EUR 25 million for third fund

    BioGeneration Ventures announced a EUR 25 million ($27.8 million) first close for the firm's third life sciences fund. BioGeneration Capital Fund III is targeting a final close of EUR 50 million ($55.6 million). LPs …

    Published on 7/5/2016
  • FINANCIAL NEWS: CStone raises $150M series A

    Chinese newco CStone Pharmaceuticals Co. Ltd. raised $150 million in a series A round from Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures. CStone, which has offices in Shanghai and Suzhou, said …

    Published on 7/5/2016
  • FINANCIAL NEWS: Medbanks raises $30M series B

    Medbanks Network Technology Co. Ltd. (Beijing, China) raised $30 million in a series B round led by Tencent. Existing investors Eight Roads Ventures China, F-Prime Capital Partners and Ping An Ventures also participated…

    Published on 7/5/2016
  • FINANCIAL NEWS: Tesaro reaps $376.7M in follow-on

    Tesaro Inc. (NASDAQ:TSRO) raised $376.7 million through the sale of 4.7 million shares at $81 in a follow-on underwritten by Citigroup, Leerink, Credit Suisse, Wells Fargo, Guggenheim, Mizuho, Raymond James, SunTrust …

    Published on 7/1/2016
  • FINANCIAL NEWS: Intercept raises $400M in debt offering

    Hepatic disease company Intercept Pharmaceutics Inc. (NASDAQ:ICPT) raised $400 million through the sale of senior convertible notes in an offering underwritten by RBC Capital Markets, UBS, BofA Merrill Lynch, Citigroup …

    Published on 6/30/2016
  • FINANCIAL NEWS: Kleiner Perkins raising new fund

    Kleiner Perkins Caufield & Byers has set a $400 million fundraising target for its Fund XVII, according to a regulatory filing. The company did not respond to inquiries.

    Published on 6/30/2016
  • FINANCIAL NEWS: Syros rises after $50M IPO

    Syros Pharmaceuticals Inc. (NASDAQ:SYRS) gained $5.65 (45%) to $18.15 on its first day of trading Thursday after raising $50 million through the sale of 4 million shares at $12.50 in an IPO. The price valued Syros at $…

    Published on 6/30/2016
  • FINANCIAL NEWS: Vidac raises $9M series A round

    Vidac Pharma (Jerusalem, Israel) raised $9 million in a series A financing led by new investor Israel Biotech Fund. Existing investors including Mivtach Shamir Holdings also participated. The company's VDA-1102 ointment…

    Published on 6/30/2016
  • FINANCIAL NEWS: JDP raises $17M in series A

    JDP Therapeutics Inc. (Blue Bell, Pa.) said it raised $17 million in a series A round led by CoSci Med-Tech Co. Ltd. (Beijing, China). JDP plans to start a Phase III study of lead candidate JDP-205, an IV formulation of…

    Published on 6/29/2016
  • FINANCIAL NEWS: Biotech stocks bounce after Brexit woes

    Biotech indices rebounded Tuesday, taking back some of their losses following last week's Brexit vote. The BioCentury 100 Index gained 176.16 (4%) to 4,584.23, with gainers outnumbering decliners 97-3. It had slid 8.1% …

    Published on 6/28/2016
  • FINANCIAL NEWS: Intensity raises $10M in series A

    Intensity Therapeutics Inc. (Westport, Conn.) said it raised $10 million in an oversubscribed series A financing from Batterson Venture Capital, VCapital, FastForward Innovations, SalvaRx Group, Declan Doogan and Jim …

    Published on 6/28/2016
  • FINANCIAL NEWS: Storm Therapeutics raises L12M in series A round

    Storm Therapeutics Ltd. (Cambridge, U.K.) raised L12 million ($16.1 million) in a series A round from existing investors Imperial Innovations Group plc (LSE:IVO), Cambridge Innovation Capital, Merck Ventures and Pfizer …

    Published on 6/28/2016
  • FINANCIAL NEWS: Biotech stocks' slide continues

    Biotech stocks sank again Monday as global markets continued to react to news of last week's Brexit vote. The BioCentury 100 lost 144.22 (3.2%) to 4,408.07, with decliners outpacing gainers 95-5. The close was the index…

    Published on 6/27/2016
  • FINANCIAL NEWS: Biotechs sink, markets hammered on Brexit news

    Biotech stocks sank Friday amid a worldwide sell-off on news that U.K. voters approved a referendum to leave the EU. The BioCentury 100 Index fell 246.47 (5.1%) to 4,552.30, with decliners outnumbering gainers 97-3.The …

    Published on 6/24/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993